
|Articles|November 14, 2022
What's New on Dermatology Times®: November 14-18
Author(s)Kaitlyn Bader, Associate Editor
Click here to see a preview of what to expect this week.
Advertisement
Some of the content the staff at Dermatology Times® will be publishing this week includes:
How to distinguish melanomas, pigmented squamous, and pigmented basal cell skin cancers from other, less dangerous skin conditions;
Off-label therapeutics that can be considered in adult and pediatric patients;
The basics of lasers and how they play a role in cosmetic dermatology;
What's new in adult and pediatric dermatology and how to incorporate dermatologic updates into clinical practice;
Exclusive video interviews with KOLs at the Society for Dermatology Physician Assistants Conference in Miami, Florida;
Plus more!
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis
2
FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis
3
Genetic Study Links Higher BMI to Perceived Facial Aging, but Causality Remains Unproven
4
Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials
5






